Market research
LVGO Livongo Health, Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 14B
- P/E ratio
- Not available
- Analyst target
- 122.13
- Dividend yield
- 0.0%
- Beta
- Not available
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US5391831030
- Market cap
- 14B
- P/E ratio
- Not available
- Analyst target
- 122.13
- Dividend yield
- 0.0%
- Beta
- Not available
About
About Livongo Health, Inc
Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. Its solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for diabetes, Livongo for hypertension, Livongo for prediabetes and weight management, and Livongo for behavioral health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California. As of October 30, 2020, Livongo Health, Inc. operates as a subsidiary of Teladoc Health, Inc.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the LVGO discussion.
5 years, 4 months ago
Livongo Health, Inc is currently in a long term uptrend where the price is trading 76.8% above its 200 day moving average.
From a valuation standpoint, the stock is 96.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 42.6.
Livongo Health, Inc's total revenue rose by 127.4% to $106M since the same quarter in the previous year.
Its net income has dropped by 29.6% to $-26M since the same quarter in the previous year.
Finally, its free cash flow fell by 60.5% to $-28M since the same quarter in the previous year.
Based on the above factors, Livongo Health, Inc gets an overall score of 3/5.